Skip to main content

Table 4 Main KEGG pathways significantly relating to major hubs

From: Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma

Term

Pathway

Count

Pop Hits

P Value

hsa05200

Pathways in cancer

41

393

6.63E−27

hsa05161

Hepatitis B

27

145

1.73E−23

hsa05205

Proteoglycans in cancer

23

200

3.70E−15

hsa04151

PI3K-Akt signaling pathway

23

345

2.43E−10

hsa05166

HTLV-I infection

19

254

2.58E−09

hsa05206

MicroRNAs in cancer

19

286

1.70E−08

hsa05152

Tuberculosis

18

177

6.66E−11

hsa04510

Focal adhesion

18

206

7.34E−10

hsa05219

Bladder cancer

17

41

1.18E−20

hsa04066

HIF-1 signaling pathway

17

96

4.41E−14

hsa05160

Hepatitis C

17

133

8.19E−12

hsa04010

MAPK signaling pathway

17

253

1.11E−07

hsa05210

Colorectal cancer

16

62

7.74E−16

hsa05212

Pancreatic cancer

16

65

1.78E−15

hsa05215

Prostate cancer

16

88

2.09E−13

hsa05142

Chagas disease (American trypanosomiasis)

16

104

2.67E−12

hsa05145

Toxoplasmosis

16

110

6.18E−12

hsa05164

Influenza A

16

174

4.54E−09

hsa05223

Non-small cell lung cancer

15

56

4.75E−15

hsa04012

ErbB signaling pathway

15

87

3.24E−12